-- Allergan agrees to Actavis deal for $66 billion
-- By Caroline Humer
-- Mon Nov 17, 2014 09:20AM EST
-- None



Nov 17 (Reuters) - Allergan Inc <AGN.N> agreed to be bought by Actavis Plc <ACT.N> for $66 billion, more than $12 billion above the current value of a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc <VRX.TO>.

